Pfizer acknowledged that It plans to submit the trial results to the U.S. Merck is the first firm to report the results of a coronavirus drug trial. As a reminder, the Optimus Pharma laboratory, from which a million tablets were purchased, has not proved that it holds a license from Merck to manufacture Molnupiravir. Optimus…
